Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia

23 May 2018

Abstract excerpt

Little data exists predicting the resistance to actinomycin D (Act-D) single-agent for gestational trophoblastic neoplasia (GTN). The objective was to determine the overall success of pulse Act-D and the factors predictive of resistance to pulse Act-D in the treatment of low-risk, non-choriocarcinoma post-molar GTN. From January 2013 to October 2016, according to the FIGO criteria for the diagnosis of post-molar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gestational Trophoblastic Disease Studies
Share to Maternal and fetal healthcare
Share to Pregnancy and preeclampsia studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29792175
DOI: 10.1186/s12885-018-4512-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasiaPMID 29792175Read ↗

Direct Comparisons of Efficacy and Safety Between Actinomycin-D and Methotrexate in Women With Low-Risk Gestational Trophoblastic Neoplasia: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed diseaseSemantic proximity Read ↗

Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasiaSemantic proximity Read ↗

Identification of cell cycle dependent methotrexate resistance in placenta site trophoblastic tumorsSemantic proximity Read ↗

Gestational Trophoblastic Disease in BrazilSemantic proximity Read ↗

Novel lnc-HZ03 and miR-hz03 promote BPDE-induced human trophoblastic cell apoptosis and induce miscarriage by upregulating p53/SAT1 pathwaySemantic proximity Read ↗

Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapySemantic proximity Read ↗

LINE-1 Methylation Patterns as a Predictor of Postmolar Gestational Trophoblastic Neoplasia.Semantic proximity Read ↗

PREDICT‐ GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?Semantic proximity Read ↗

PD‐L1, B7‐H3 and VISTA are highly expressed in gestational trophoblastic neoplasiaSemantic proximity Read ↗

Presence of the methylenetetrahydrofolate reductase gene polymorphism MTHFR C677T in molar tissue but not maternal blood predicts failure of methotrexate treatment for low-risk gestational trophoblastic neoplasia.Semantic proximity Read ↗

MethotrexateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.